Plasmodium vivax: Paroxysm-associated lipids mediate leukocyte aggregation

Malaria Journal

Volumn 6, Issue , 2007, Pages

  Karunaweera, Nadira ^a   Wanasekara, Deepani ^a   Chandrasekharan, Vishvanath ^a   Mendis, Kamini ^a   Carter, Richard ^b  

^a UNIVERSITY OF COLOMBO   (Sri Lanka)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 6; LIPID; PHOSPHOLIPID; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ANTIGENICITY; ARTICLE; BIOCHEMISTRY; BIOLOGICAL ACTIVITY; BLOOD SMEAR; CONTROLLED STUDY; DEPLETION; ENZYME RECONSTITUTION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; LEUKOCYTE AGGREGATION; LIPID ANALYSIS; MALARIA; MALE; MEDIATOR; MICROSCOPE; PARASITE; PLASMA; PLASMA FACTOR; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; SCHIZONT; WHOLE CELL; ANIMAL; BLOOD; CELL AGGREGATION; CYTOLOGY; DRUG EFFECT; FEVER; LEUKOCYTE; METABOLISM;

ANIMALS; CELL AGGREGATION; CYTOKINES; FEVER; HUMANS; LEUKOCYTES; LIPIDS; MALARIA, VIVAX; PLASMODIUM VIVAX;

EID: 34250311732     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-6-62     Document Type: Article

References (46)

1. Tumour necrosis factor dependent parasite-killing effects during paroxysms in non-immune Plasmodium vivax malaria patients. ND Karunaweera R Carter GE Grau D Kwiatkowski Del Giudice G KN Mendis, Clin Exp Immunol 1992 88 499 505 1351432
2. A malaria parasite toxin associated with Plasmodium vivax paroxysms. SK Wijesekera R Carter L Rathnayake KN Mendis, Clin Exp Immunol 1996 104 221 227 10.1046/j.1365-2249.1996.07699.x 8625512
3. Dynamics of fever and serum levels of tumour necrosis factor are closely associated during clinical paroxysms in non-immune Plasmodium vivax malaria patients. ND Karunaweera GE Grau P Gamage R Carter KN Mendis, Proc Natl Acad Sci USA 1992 89 3200 3203 1565611 10.1073/pnas.89.8.3200
4. Transient increase in circulating T cells during Plasmodium vivax malarial paroxysms. MK Perera R Cater R Goonewardene KN Mendis, J Exp Med 1994 179 311 315 10.1084/jem.179.1.311 8270875
5. Characteristics of malaria transmission in Kataragama, Sri Lanka: a focus for immuno-epidemiological studies. C Mendis A Gamage-Mendis APK De Zoysa TA Abhayawardena R Carter PRJ Herath KN Mendis, Am J Trop Med Hyg 1990 42 298 308 2184688
6. Demonstration of anti-disease immunity to Plamodium vivax malaria in Sri Lanka using a quantitative method to assess clinical disease. ND Karunaweera R Carter GE Grau KN Mendis, Am J Trop Med Hyg 1998 58 204 210 9502605
7. Panninng" for lymphocytes: A method for cell selection. LJ Wysocki VL Sato, Proc Natl Acad Sci USA 1978 75 2844 2848 351618 10.1073/pnas.75.6.2844
8. Anti-parasite effects of cytokines in malaria. KN Mendis S Naotunna T de ND Karunaweera GD Giudice GE Grau R Carter, Immunol Lett 1990 25 217 220 10.1016/0165-2478(90)90118-A 2126526
9. Differentiation of osmotic and secretory diarrhoea by stool carbohydrate and osmolar gap measurements. JA Castro-Rodríguez E Salazar-Lindo R León-Barúa, Arch Dis Child 1997 77 201 205 9370895
10. Aliphatic lipids. HR Bolliger M Brenner H Ganshirt HK Mangold H Seiler E Stahl D Waldi, Thin Layer Chromatography - A Laboratory Handbook Berlin: Springer Publishing, Stahl E, 1965 137 181
11. Lipids. PA Mayes, Harper's Review of Biochemistry Lange Medical Publications, Los Altos, California, USA, Martin DW, Mayes PA, Rodwell VW, 19 1983 188 200
12. Lipids of Physiologic Significance. PA Mayes, Harper's Biochemistry Appleton and Lange, Norwalk, Connecticut, Murray RK, Grammar DK, Mayes PA, Rodwell VW, 23 1993 142 153
13. The paroxysm of Plasmodium vivax malaria. ND Karunaweera SK Wijesekara D Wanasekera KN Mendis R Carter, Trends Parasitol 2003 19 188 193 10.1016/S1471-4922(03)00036-9 12689650
14. Macrophage activation in vivax malaria; fever is associated with increased levels of neopterin and interferon-gamma. AE Brown P Teja-Isavadharm HK Webster, Parasite Immunol 1991 13 673 679 1811217
15. Possible roles of tumor necrosis factor in the pathology of malaria. IA Clark WB Cowden GA Butcher NH Hunt, Am J Pathol 1987 129 192 199 3661678
16. Role of polymorphonuclear neutrophil leukocytes and their integrin CD11a (LFA-1) in the pathogenesis of severe murine malaria. G Senaldi C Vesin R Chang GE Grau PF Piguet, Infect Immun 1994 62 1144 1149 8132319
17. Pulmonary oedema in vivax malaria. S Pukrittayakamee A Chantra S Vanijanonta NJ White, Trans R Soc Trop Med Hyg 1998 92 421 422 10.1016/S0035-9203(98)91075-6 9850397
18. Ultrastructural analysis of fresh Plasmodium falciparum -infected erythrocytes and their cytoadherence to human leukocytes. W Ruangirachuporn BA Afzelius H Helmby AV Hill BM Greenwood J Carlson K Bersins P Perlmann M Wahlgren, Am J Trop Med Hyg 1992 46 511 519 1599044
19. Changes in erythrocyte sedimentation rate, C-reactive protein and hematological parameters in patients with acute malaria. B Eriksson U Hellgren L Rombo, Scand J Infect Dis 1989 21 434 441 2587946
20. Hematologic changes in acute, imported Plasmodium falciparum malaria. MW Richards RH Behrens JF Doherty, Am J Trop Med Hyg 1998 59 859 9886188
21. BJ Bain, Blood Cells: A Practical Guide London: Lippincott/Gower Medical Publishing 1989
22. Malarial toxins and the regulation of parasite density. D Kwaitkowski, Parasitol Today 1995 11 206 212 10.1016/0169-4758(95)80079-4 15275344
23. Experimental Studies in Yellow Fever and Malaria at Vera Cruz, Mexico. MJ Rosenau HB Parker E Francis GE Beyer, Report of Working Party No. 2, Yellow Fever Institute Washington: Government Printing Office 1905
24. Antitoxin approach to malaria. IA Clark, Lancet 2002 360 1983 10.1016/S0140-6736(02)11888-5 12493306
25. Malaria: toxins, cytokines and disease. PH Jakobsen CAW Bate J Taverne JHL Playfair, Parasite Immunol 1995 17 223 231 7675508
26. TNF-inducing malaria toxin: a sheep in wolf's clothing? D Kwaitkowski, Ann Trop Med Parasit 1993 87 613 616 8122924
27. High levels of inducible nitric oxide synthase mRNA are associated with increased monocyte counts in blood and have a beneficial role in Plasmodium falciparum malaria. CB Chiwakata CJ Hemmer M Dietrich, Infect Immun 2000 68 394 399 10603415
28. Early cytokine induction by Plasmodium falciparum is not a classical endotoxin-like process. IG Scragg M Hensmann CAW Bate D Kwiatkowski, Eur J Immunol 1999 29 2636 2644 10.1002/(SICI)1521-4141(199908)29:08<2636::AID- IMMU2636>3.0.CO;2-Y 10458778
29. Macrophage activation in vivax malaria: fever is associated with increased levels of neopterin and interferon-gamma. AE Brown P Teja-Isavadharm HK Webster, Parasite Immunol 1991 13 673 679 1811217
30. Cell mediated immunity in protection and pathology of malaria. IA Clark, Parasitol Today 1987 10 300 306 10.1016/0169-4758(87)90187-6
31. Immunity to asexual blood stages of Plasmodium: Is resistance to acute malaria adaptive or innate? AH Fell NC Smith, Parasitol Today 1998 14 364 368 10.1016/S0169-4758(98)01298-8 17040818
32. Cell mediated immunity to Plasmodium vivax infection: in vitro inhibition of parasite growth by monocyte derived macrophages. K Jagadeesan MP Korath S Seetha Lakshmi S Elankumaran, J Assoc Physicians India 1999 47 955 957 10778685
33. Paroxysm serum from a case of Plasmodium vivax malaria inhibits the maturation of P. falciparum schizonts in vitro. Y Nagao P Chavalitshewinkoon- Petmitr H Noedl S Thongrungkiat S Krudsood Y Sukthana M Nacher P Wilairatana S Looareesuwan, Ann Trop Med Parasitol 2003 97 587 592 10.1179/000349803225001409 14511557
34. Mediators and mechanisms associated with paroxysm in Plasmodium vivax malaria. R Carter SK Wijesekera ND Karunaweera KN Mendis, J Pharm Pharmacol 1997 49 Suppl 2 35 41
35. V gamma 9V delta 2 T-cell anergy and complementarity-determining region 3-specific depletion during paroxysms of non endemic malaria infection. F Martini MG Paglia C Montesano PJ Enders M Gentile CD Pauza C Gioia V Colizzi P Narciso LP Pucillo F Poccia, Infect Immun 2003 71 2945 2949 12704176 10.1128/IAI.71.5.2945-2949.2003
36. Human T cell proliferative responses to Plasmodium vivax antigens: evidence of immunosupression following prolonged exposure to endemic malaria. R Goonewardene R Carter CP Gamage G Del-Giudice PH David S Howie KN Mendis, Eur J Immunol 1990 20 1387 1391 10.1002/eji.1830200626 2196178
37. Antibodies to Plasmodium falciparum glycosylphosphatidylinositols: Inverse association with tolerance of parasitemia in Papua New Guinean children and adults. CS Boutlis DC Gowda RS Naik GP Maguire CS Mgone MJ Bockarie ML Ibam EK Lorry NM Anstey, Infect Immun 2002 70 5052 5057 12183552 10.1128/IAI.70.9. 5052-5057.2002
38. Immunoglobulin G (IgG) responses to Plasmodum falciparum glycosylphosphatidylinositols are short-lived and predominantly of the IgG3 subclass. CS Boutlis PK Fagan DC Gowda M Lagog CS Mgone MJ Bockarie NM Anstey, J Infect Dis 2003 187 862 865 10.1086/367897 12599061
39. Genes for glycosylphosphatidylinositol toxin biosynthesis in Plasmodium falciparum. M Delorenzi A Sexton H Shams-Eldin RT Schwarz T Speed L Schofield, Infect Immun 2002 70 4510 4522 12117963 10.1128/IAI.70.8.4510-4522.2002
40. What can GPI do for you? MAJ Ferguson, Parasitol Today 1994 10 48 52 10.1016/0169-4758(94)90392-1 15275498
41. Glycosylphosphatidylinositol anchors of Plasmodium falciparum : molecular characterization and naturally elicited antibody response that may provide immunity to malaria pathogenesis. RS Naik OH Branch AS Woods M Vijaykumar DJ Perkins BL Nahlen AA Lal RJ Cotter CE Costello CF Ockenhouse EA Davidson DC Gowda, J Exp Med 2000 192 1563 1576 10.1084/jem.192.11.1563 11104799
42. Synthetic GPI as a candidate antitoxin vaccine in a model of malaria. L Schofield MC Hewitt K Evans MA Slomos PH Seeberger, Nature 2002 418 785 789 10.1038/nature00937 12181569
43. Prevalence and boosting of antibodies to Plasmodium falciparum glycosylphosphatidylinositols and evaluation of their association with protection from mild and severe clinical malaria. de Souza JB J Todd G Krishegowda DC Gowda D Kwiatkowski EM Riley, Infect Immun 2002 70 5045 5051 12183551 10.1128/IAI.70.9.5045-5051.2002
44. Malaria vaccines. RF Anders A Saul, Parasitol Today 2000 16 444 454 10.1016/S0169-4758(00)01784-1 11006477
45. Plasmodium vivax : Merozoites, invasion of reticulocytes and consideration for malaria vaccine development. MR Galinski, Parasitol Today 1996 12 20 29 10.1016/0169-4758(96)80641-7 15275304
46. Polar Plasmodium falciparum. lipids induce lipogenesis in rats adipocytes in vitro. S Zakeri K Taylor JL Goad M Hommel, Microbes Infect 2000 2 1789 98 10.1016/S1286-4579(00)01334-4 11165922